Effects of mosapride, a 5-hydroxytryptamine 4 receptor agonist, on electrical activity of the small intestine and cecum in horses

American Journal of Veterinary Research

Volumn 66, Issue 8, 2005, Pages 1321-1323

  Sasaki, Naoki ^a   Okamura, Kouichi ^b   Yamada, Haruo ^a  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^b DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MOSAPRIDE; MOSAPRIDE CITRATE; SEROTONIN 4 AGONIST; BENZAMIDE DERIVATIVE; MORPHOLINE DERIVATIVE; SEROTONIN 4 RECEPTOR;

ARTICLE; CALCULATION; CECUM; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFECT; ELECTRIC ACTIVITY; ELECTROGASTROGRAPHY; GASTROINTESTINAL DISEASE; INTESTINE MOTILITY; NASOGASTRIC TUBE; NONHUMAN; SMALL INTESTINE; ANIMAL; DOSE RESPONSE; DRUG POTENTIATION; ELECTROPHYSIOLOGY; GASTROINTESTINAL MOTILITY; HORSE; PHYSIOLOGY;

ANIMALIA; EQUIDAE;

ANIMALS; BENZAMIDES; CECUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; GASTROINTESTINAL MOTILITY; HORSES; INTESTINE, SMALL; MORPHOLINES; RECEPTORS, SEROTONIN, 5-HT4;

EID: 26944438018     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2005.66.1321     Document Type: Article

References (25)

1. Sasaki N, Hara S. Medical treatment to equine gastrointestinal dysfunctions. J Equine Sci 2003;14:37-49.
2. Chen JD, Ke MY, Lin XM, et al. Cisapride provides symptomatic relief in functional dyspepsia associated with gastric myoelectrical abnormality. Aliment Pharmacol Ther 2000;14:1041-1047.
3. Kato S, Fujiwara I, Yoshida N. Nitrogen-containing heteroalicycles with serotonin receptor binding affinity: development of gastroprokinetic and antiemetic agents. Med Res Rev 1999;19:25-73.
4. Morie T, Kato S, Harada H, et al. Synthesis and biological activities of the optical isomers of (+/-)-4-amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl) -2-morpholinyl]methyl]benzamide (mosapride). Chem Pharm Bull (Tokyo) 1994;42:877-882.
5. Ruth M, Finizia C, Cange L, et al. The effect of mosapride on oesophageal motor function and acid reflux in patients with gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2003;15:1115-1121.
6. Kanaizumi T, Nakano H, Matsui T, et al. Effect of AS-4370 on gastric emptying - double-blind clinical pharmacological study. Nippon Heikatsukin Gakkai Zasshi 1990;26:161-174.
7. Kanaizumi T, Nakano H, Matsui Y, et al. Prokinetic effect of AS-4370 on gastric emptying in healthy adults. Eur J Clin Pharmacol 1991;41:335-337.
8. Sasaki N, Lee I, Ayukawa Y, et al. Effects of orally administrated mosapride, a 5-HT4 receptor agonist, on the digestive tract of horses. J Equine Sci 2004;15:81-84.
9. Sasaki N, Lee I, Ayukawa Y, et al. Clinical applications of electrointestinography in the horse. J Equine Sci 2004;15:85-92.
10. Chen JD, McCallum RW. Clinical applications of electrogastrography. Am J Gastroenterol 1993;88:1324-1336.
11. Kajimoto T. Relation between electrogastrography and gastric electromyogram, mechanical activity. J Smooth Muscle Res 1995;31:93-107.
12. Michel A, Mevissen M, Burkhardt HW, et al. In vitro effects of cisapride, metoclopramide and bethanechol on smooth muscle preparations from abomasal antrum and duodenum of dairy cows. J Vet Pharmacol Ther 2003;26:413-420.
13. Sasaki N, Yoshihara T. The effect of orally administered cisapride on intestinal motility in conscious horses. J Vet Med Sci 2000;62:211-213.
14. Bran S, Murray WA, Hirsch IB, et al. Long QT syndrome during high-dose cisapride. Arch Intern Med 1995;155:765-768.
15. Carlsson L, Amos GJ, Andersson B, et al. Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: implications for proarrhythmic potential? J Pharmacol Exp Ther 1997;282:220-227.
16. Kii Y, Ito T. Effects of 5-HT4-receptor agonists, cisapride, mosapride citrate, and zacopride, on cardiac action potentials in guinea pig isolated papillary muscles. J Cardiovasc Pharmacol 1997;29:670-675.
17. Yoshida N, Omoya H, Oka M, et al. AS-4370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties. Arch Int Pharmacodyn Ther 1989;300:51-67.
18. Yoshikawa T, Yoshida N, Mine Y, et al. Affinity of mosapride citrate, a new gastroprokinetic agent, for 5-HT4 receptors in guinea pig ileum. Jpn J Pharmacol 1998;77:53-59.
19. Taniyama K, Nakayama S, Takeda K, et al. Cisapride stimulates motility of the intestine via the 5-hydroxytryptamine receptors. J Pharmacol Exp Ther 1991;258:1098-1104.
20. Weiss R, Abel D, Scholtysik G, et al. 5-Hydroxytryptamine mediated contractions in isolated preparations of equine ileum and pelvic flexure: pharmacological characterization of a new 5-HT(4) agonist. J Vet Pharmacol Ther 2002;25:49-58.
21. Kato S, Morie T, Kon T, et al. Novel benzamides as selective and potent gastrokinetic agents. 2. Synthesis and structure-activity relationships of 4-amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)-2-morpholinyl]methyl] benzamide citrate (AS-4370) and related compounds. J Med Chem 1991;34:616-624.
22. Kato S, Morie T, Yoshida N. Synthesis and biological activities of metabolites of mosapride, a new gastroprokinetic agent. Chem Pharm Bull (Tokyo) 1995;43:699-702.
23. Mine Y, Yoshikawa T, Oku S, et al. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro. J Pharmacol Exp Ther 1997;283:1000-1008.
24. Yoshida N, Ito T, Karasawa T, et al. AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs. J Pharmacol Exp Ther 1991;257:781-787.
25. Yoshida N, Omoya H, Kato S, et al. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals. Arzneimittelforschung 1993;43:1078-1083.